Friday, May 1, 2026

2026 PRP Kit Revolution: How Humedix and Medisarang Are Transforming Regenerative Medicine

Humedics and Medisarang partner to develop regenerative medicine devices, focusing on PRP kits for aesthetics and other medical fields.

Heartbreaking Trends: Suicide Rates Hit Record Highs in South Korea

The number of suicides in South Korea last year reached approximately 14,000, marking an 8.3% increase compared to the previous year.

CHINA’S Blackmail: Trump’s Urgent Rare Earth Buy Signals America Is One Export Ban Away From Total Defense COLLAPSE

Trump expands his investment portfolio to include quantum computing, rare earth, and semiconductor firms, focusing on national interests.

Tag: development

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

ABL209 Receives FDA Approval: What This Dual Antibody ADC Means for Cancer Treatment

ABL Bio receives FDA approval for ABL209, a bispecific antibody-drug conjugate, advancing ADC development for solid tumors.

Unlocking Weight Loss: How Celltrion’s New CT-G32 and Oral Multi-Action Drug Will Change the Game

Celltrion aims to lead the obesity treatment market with innovative drugs, enhancing efficacy and patient convenience through dual approaches.

South Korean Biotech Seeks Breakthrough in $Trillion-Scale Alzheimer’s Market

AriBio's AR1001 is a promising oral Alzheimer's drug aiming for global blockbuster status by 2027, focusing on convenience and safety.

How Ildong Bioscience is Revolutionizing Health Supplements at Vitafoods India 2026

Ildong Bioscience participated in the 2026 Vitafoods India expo, showcasing innovative health products and seeking partnerships in the healthcare sector.

Can Samjin Pharm Overcome Generic Drug Price Cuts With AI-Driven Drug Development?

Samjin Pharm shifts focus to R&D, moving away from generics to innovative drug development, amid government price cuts.

CT-P55: How Celltrion’s New Biosimilar Approval Will Transform Clinical Trials in Europe

Celltrion receives EMA approval to reduce patient enrollment for CT-P55 trial, aiming to cut costs and duration of clinical development.

Unlocking Weight Loss: Hanmi Pharmaceutical’s Innovative H.O.P Project and the Game-Changing Epaglenatide

Hanmi Pharmaceutical is innovating obesity treatment with efpeglenatide and HM15275, focusing on tailored solutions for Korean patients.

Hanmi Posts Record $1.16B Sales and $193M Operating Profit: What’s Driving the 2025 Surge

Hanmi Pharmaceutical reports record sales of $1.16 billion in January 2025, with significant growth in profits and new product launches.

K-Beauty Boom: How Classys, Hugel, and Wontech are Expanding in Global Markets

The K-beauty industry is growing, leveraging strong manufacturing and R&D capabilities alongside the global spread of Hallyu.

Celltrion Gets Global IB Upgrades: Morgan Stanley Raises Target to $206.25 as New Biosimilars Lift Margins

Celltrion is expanding through biosimilars and new drug development, attracting global investor interest and raising target stock prices.

SJN314: The Promising New Immunotherapy for Chronic Inflammatory Diseases in Asia

Samjin Pharmaceutical submits phase 1 trial plan for SJN314, targeting immune diseases, aiming for global partnerships in early clinical phases.

HM15275 Clinical Trials: What You Need to Know About This Groundbreaking Obesity Treatment

Hanmi Pharmaceutical's HM15275 enters Phase 2 trial, aiming to revolutionize obesity treatment and diabetes management by 2030.

Celltrion’s Zymfentra: How This Breakthrough Drug is Driving Record Sales

Celltrion expects record sales driven by Zymfentra's success, expanding into new biosimilars and CDMO business for future growth.

How AI is Revolutionizing Coding: 30% of Code Now Generated by AI!

AI is rapidly replacing human programmers in coding, with significant productivity gains and changing job demands in the tech industry.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.